Literature DB >> 16996928

Combined atrial septal defect surgical closure and irrigated radiofrequency ablation in adult patients.

Alessandro Giamberti1, Massimo Chessa, Sara Foresti, Raul Abella, Gianfranco Butera, Carlo de Vincentiis, Mario Carminati, Lorenzo Menicanti, Alessandro Frigiola.   

Abstract

BACKGROUND: Atrial arrhythmias are relatively common among patients over 40 years old with atrial septal defect (ASD) and are a precipitating cause of heart failure. Surgical closure of the ASD in these patients is feasible and is associated with a low mortality rate and a beneficial effect on the clinical status; however the occurrence of atrial arrhythmia does not decrease after surgery. We present the results of our preliminary experience with surgical ASD closure combined with intraoperative irrigated radiofrequency (IRF) ablation in adult patients.
METHODS: During a 26-month period between September 2002 and December 2004, 15 patients more than 40 years old with ASD and atrial arrhythmia underwent elective surgical closure of the defect and intraoperative IRF ablation. All patients had supraventricular arrhythmias: 8 had permanent atrial fibrillation, whereas 7 had previous episodes of atrial flutter or intra-atrial reentry tachycardia. The biatrial approach (Cox-Maze III procedure) was used in 7 patients and a right-sided Maze procedure (ablation lines on the right atrium only) was carried out in the remaining 8 patients.
RESULTS: All patients survived the procedure. Fourteen patients left the operating room in sinus rhythm and 1 had a pacemaker implanted. There were no complications resulting from the IRF ablation. All 15 patients survived over the average follow-up period of 24 months. Thirteen patients were still in sinus rhythm, 1 had pacemaker rhythm, and only 1 (1 of 15; 6.5%) suffered a recurrence of atrial fibrillation 3 months after the procedure.
CONCLUSIONS: We suggest adding intraoperative IRF ablation during surgical closure of an ASD in all adult ASD patients with arrhythmias. The IRF ablation is easy to perform, safe, and effective.

Entities:  

Mesh:

Year:  2006        PMID: 16996928     DOI: 10.1016/j.athoracsur.2006.05.010

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 2.  Prophylactic arrhythmia surgery in association with congenital heart disease.

Authors:  Constantine Mavroudis; Barbara J Deal
Journal:  Transl Pediatr       Date:  2016-07

Review 3.  Surgical treatment for adult congenital heart disease: consideration for indications and procedures.

Authors:  Kozo Matsuo; Masashi Kabasawa; Soichi Asano; Shigeru Tateno; Yasutaka Kawasoe; Yoshitomo Okajima; Naoki Hayashida; Hirokazu Murayama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-11-08

4.  Biatrial ablation versus limited right atrial ablation for atrial fibrillation associated with atrial septal defect in adults.

Authors:  Zhaolei Jiang; Nan Ma; Hang Yin; Fangbao Ding; Hao Liu; Ju Mei
Journal:  Surg Today       Date:  2014-08-09       Impact factor: 2.549

5.  Pathophysiology and Management of Arrhythmias Associated with Atrial Septal Defect and Patent Foramen Ovale.

Authors:  Henry Chubb; John Whitaker; Steven E Williams; Catherine E Head; Natali Ay Chung; Matthew J Wright; Mark O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

6.  Preliminary Results of Cryoablation for Surgical Treatment of Arrhythmias in Adults With Congenital Heart Disease.

Authors:  Giulia Poretti; Stiljan Hoxha; Antonio Segreto; Gardellini Jacopo; Camilla Sandrini; Giuseppe Faggian; Alessandro Varrica; Massimo Chessa; Alessandro Giamberti; Giovanni Battista Luciani
Journal:  Front Cardiovasc Med       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.